Evidence map›Paper›PMID 27457058›Full record

ArticleJournal of clinical laboratory analysis2017

Serum Total Sialic Acid Level is Elevated in Hypothyroid Patients as an Atherosclerotic Risk Factor.

Mustafa Altay, Mehmet Ayhan Karakoç, Nuri Çakır, Canan Yılmaz Demirtaş, Ethem Turgay Cerit, Müjde Aktürk, İhsan Ateş, Neslihan Bukan, Metin Arslan

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mustafa AltayDepartment of Endocrinology and Metabolism, Gazi University Medical Faculty, Ankara, Turkey.
Mehmet Ayhan KarakoçDepartment of Endocrinology and Metabolism, Gazi University Medical Faculty, Ankara, Turkey.
Nuri ÇakırDepartment of Endocrinology and Metabolism, Gazi University Medical Faculty, Ankara, Turkey.
Canan Yılmaz DemirtaşClinical Biochemistry, Gazi University Medical Faculty, Ankara, Turkey.
Ethem Turgay CeritDepartment of Endocrinology and Metabolism, Gazi University Medical Faculty, Ankara, Turkey.
Müjde AktürkDepartment of Endocrinology and Metabolism, Gazi University Medical Faculty, Ankara, Turkey.
İhsan AteşDepartment of Internal Medicine, Numune Education and Research Hospital, Ankara, Turkey.
Neslihan BukanClinical Biochemistry, Gazi University Medical Faculty, Ankara, Turkey.
Metin ArslanDepartment of Endocrinology and Metabolism, Gazi University Medical Faculty, Ankara, Turkey.
Gazi University · TRAnkara Numune Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSerum total sialic acid (TSA) concentration is regarded as an indicator of the risks of atherosclerosis and cardiovascular diseases. The association between SA levels and atherosclerosis risk factors has not been assessed in patients with thyroid diseases.

methodsSixty newly diagnosed treatment-naive hypothyroid patients, 35 with subclinical and 25 with overt hypothyroidism, and 30 euthyroid individuals were analyzed. SA was measured in fasting blood samples, as were routine biochemical parameters, some atherosclerosis markers and carotid artery intima media thickness (CIMT).

resultsMean SA (38.1 ± 12.0 vs. 46.0 ±15.8; P = 0.019) and CIMT (0.57 ± 0.06 vs. 0.62 ± 0.12; P = 0.013) were found to be higher in the patient group compared with the control group. Mean sialic acid was higher in overt hypothyroidism patients compared with subclinical hypothyroidism patients and the control group. No difference was found between the subclinical hypothyroidism group and the control group. Sialic acid level and CIMT had a positive correlation in both the entire population and the hypothyroidism group. The linear regression model established for mean CIMT level in the entire population showed that risk factors of LDL (B ± SE = 0.454 ± 0.206; P = 0.030), uric acid (B ± SE = 1.902 ± 0.686; P = 0.007), hs-CRP (B ± SE = 1.003 ± 0.380; P =0.010), and SA (B ± SE = 2.419 ± 0.450; P < 0.001) were independent predictors of CIMT level.

conclusionSialic acid level is elevated in hypothyroid patients. However, this elevation is not related to thyroid hormone levels and autoantibodies. Correlations between SA and atherosclerosis indicators, such as CIMT, LDL, hs-CRP, and uric acid, in hypothyroid individuals suggest that SA may be an indicator of atherogenesis in these patients.

Indexed as

AdolescentAdultAtherosclerosisAutoantibodiesBiomarkersCardiovascular DiseasesCarotid Intima-Media ThicknessC-Reactive ProteinCross-Sectional StudiesFemaleHumansHypothyroidismLipoproteins, LDLMaleMiddle AgedN-Acetylneuraminic AcidAutoantibodiesBiomarkersC-Reactive ProteinLipoproteins, LDLN-Acetylneuraminic AcidThyroid HormonesUric Acidatherosclerosiscarotid artery intima media thicknesshypothyroidismsialic aciduric acid

Identifiers

PMID27457058
PMCPMC6817025
OpenAlexW2480862962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.